Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
NCT ID: NCT01969396
Last Updated: 2014-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
2 participants
INTERVENTIONAL
2013-10-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SonoBiopsy Catheter
SonoBiopsy Catheter
Catheter utilized in dual role: sonohysterography and endometrial biopsy
Endometrial biopsy catheter
Endometrial biopsy catheter
Endometrial sample obtained without the assistance of sonohysterography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SonoBiopsy Catheter
Catheter utilized in dual role: sonohysterography and endometrial biopsy
Endometrial biopsy catheter
Endometrial sample obtained without the assistance of sonohysterography
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Abnormal uterine bleeding
Exclusion Criteria
* Active pelvic infection
* Pelvic inflammatory disease
* Blood clotting disorders
* Sexually transmitted disease
* Uterine perforation
* Recent cesarean section
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cook Group Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ricardo Mastellari, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Punta Pacifica
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Punta Pacifica
Panama City, , Panama
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-012
Identifier Type: -
Identifier Source: org_study_id